Comment
doi: 10.1016/S1473-3099(17)30246-3.
Epub 2017 May 9.
Drug-resistant tuberculosis threatens WHO's End-TB strategy
Affiliations
- PMID: 28499827
- DOI: 10.1016/S1473-3099(17)30246-3
Item in Clipboard
Comment
Drug-resistant tuberculosis threatens WHO's End-TB strategy
Lancet Infect Dis.
2017 Jul.
No abstract available
Comment in
-
Multidrug-resistant tuberculosis: pharmacokinetic and pharmacodynamic science.Lancet Infect Dis. 2017 Sep;17(9):898. doi: 10.1016/S1473-3099(17)30449-8. Lancet Infect Dis. 2017. PMID: 28845791 No abstract available.
Comment on
-
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.Lancet Infect Dis. 2017 Jul;17(7):707-715. doi: 10.1016/S1473-3099(17)30247-5. Epub 2017 May 9. Lancet Infect Dis. 2017. PMID: 28499828 Free PMC article.
Similar articles
-
WHO's 2013 global report on tuberculosis: successes, threats, and opportunities.Lancet. 2013 Nov 30;382(9907):1765-7. doi: 10.1016/S0140-6736(13)62078-4. Epub 2013 Oct 23. Lancet. 2013. PMID: 24269294 No abstract available.
-
Multidrug-resistant tuberculosis treatment programmes insufficiently consider comorbid mental disorders.Int J Tuberc Lung Dis. 2017 Jun 1;21(6):603-609. doi: 10.5588/ijtld.17.0135. Int J Tuberc Lung Dis. 2017. PMID: 28482954
-
The most recent report from the World Health Organization found that, worldwide, approximately 5% of new tuberculosis cases are caused by multidrug-resistant strains (MDR TB).J Travel Med. 2010 May-Jun;17(3):216. doi: 10.1111/j.1708-8305.2009.00396.x. J Travel Med. 2010. PMID: 20536899 No abstract available.
-
[Drug resistant tuberculosis].Pol Merkur Lekarski. 2011 May;30(179):362-6. Pol Merkur Lekarski. 2011. PMID: 21675144 Review. Polish.
-
Getting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosis.Am J Respir Crit Care Med. 2014 Aug 15;190(4):374-83. doi: 10.1164/rccm.201402-0363PP. Am J Respir Crit Care Med. 2014. PMID: 24941306 Review.
Cited by
-
Drug resistant tuberculosis in Africa: Current status, gaps and opportunities.Afr J Lab Med. 2018 Dec 6;7(2):781. doi: 10.4102/ajlm.v7i2.781. eCollection 2018. Afr J Lab Med. 2018. PMID: 30568900 Free PMC article.
-
Multidrug-Resistant Tuberculosis Treatment Outcome and Associated Factors at the University of Gondar Comprehensive Specialized Hospital: A Ten-Year Retrospective Study.Infect Drug Resist. 2022 Jun 3;15:2891-2899. doi: 10.2147/IDR.S365394. eCollection 2022. Infect Drug Resist. 2022. PMID: 35686191 Free PMC article.
-
Age-stratified anti-tuberculosis drug resistance profiles in South Korea: a multicenter retrospective study.BMC Infect Dis. 2020 Jun 23;20(1):446. doi: 10.1186/s12879-020-05157-6. BMC Infect Dis. 2020. PMID: 32576154 Free PMC article.
-
Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey.Int J Infect Dis. 2019 Oct;87:119-125. doi: 10.1016/j.ijid.2019.07.021. Epub 2019 Jul 27. Int J Infect Dis. 2019. PMID: 31357057 Free PMC article.
-
Effects of secondary infections on the multidrug-resistant Tuberculosis: A cohort study.Med J Islam Repub Iran. 2021 Aug 17;35:105. doi: 10.47176/mjiri.35.105. eCollection 2021. Med J Islam Repub Iran. 2021. PMID: 34956951 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
